These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 26732135)

  • 1. Is there association between vitamin D levels, apelin 36, and visfatin in PCOS?
    Kiyak Caglayan E; Engin-Üstun Y; Sari N; Göçmen AY; Seckin L; Kara M; Metin A; Polat MF
    Gynecol Endocrinol; 2016; 32(5):386-9. PubMed ID: 26732135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of insulin resistance and plasma levels for visfatin and resistin in obese and non-obese patients with polycystic ovary syndrome.
    Gul OO; Cander S; Gul B; Açıkgoz E; Sarandol E; Ersoy C
    Eur Cytokine Netw; 2015; 26(4):73-8. PubMed ID: 26967765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between serum apelin, visfatin levels, and body composition in Polycystic Ovary Syndrome patients.
    Kuai D; Tang Q; Wang X; Yan Q; Tian W; Zhang H
    Eur J Obstet Gynecol Reprod Biol; 2024 Jun; 297():24-29. PubMed ID: 38555852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of metformin on serum visfatin levels in patients with polycystic ovary syndrome.
    Ozkaya M; Cakal E; Ustun Y; Engin-Ustun Y
    Fertil Steril; 2010 Feb; 93(3):880-4. PubMed ID: 19111298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating anti-Müllerian hormone levels in relation to nutritional status and selected adipokines levels in polycystic ovary syndrome.
    Olszanecka-Glinianowicz M; Madej P; Owczarek A; Chudek J; Skałba P
    Clin Endocrinol (Oxf); 2015 Jul; 83(1):98-104. PubMed ID: 25440474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum visfatin levels in women with polycystic ovary syndrome.
    Güdücü N; İşçi H; Görmüş U; Yiğiter AB; Dünder I
    Gynecol Endocrinol; 2012 Aug; 28(8):619-23. PubMed ID: 22313145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adipokines, insulin resistance and hyperandrogenemia in obese patients with polycystic ovary syndrome: cross-sectional correlations and the effects of weight loss.
    Spanos N; Tziomalos K; Macut D; Koiou E; Kandaraki EA; Delkos D; Tsourdi E; Panidis D
    Obes Facts; 2012; 5(4):495-504. PubMed ID: 22854419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of new adipocytokines and insulin resistance in adolescents with polycystic ovary syndrome.
    Cekmez F; Cekmez Y; Pirgon O; Canpolat FE; Aydinöz S; Metin Ipcioglu O; Karademir F
    Eur Cytokine Netw; 2011 Mar; 22(1):32-7. PubMed ID: 21411410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are plasma levels of visfatin and retinol-binding protein 4 (RBP4) associated with body mass, metabolic and hormonal disturbances in women with polycystic ovary syndrome?
    Olszanecka-Glinianowicz M; Madej P; Zdun D; Bożentowicz-Wikarek M; Sikora J; Chudek J; Skałba P
    Eur J Obstet Gynecol Reprod Biol; 2012 May; 162(1):55-61. PubMed ID: 22397743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma visfatin and apelin levels in adolescents with polycystic ovary syndrome.
    Ruan X; Li M; Min M; Ju R; Wang H; Xu Z; Luo S; Mueck AO
    Gynecol Endocrinol; 2023 May; 39(1):2216807. PubMed ID: 37248950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-visfatin levels in women with polycystic ovary syndrome: evidence from a meta-analysis.
    Sun Y; Wu Z; Wei L; Liu C; Zhu S; Tang S
    Gynecol Endocrinol; 2015 Oct; 31(10):808-14. PubMed ID: 26422683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D-associated polymorphisms are related to insulin resistance and vitamin D deficiency in polycystic ovary syndrome.
    Wehr E; Trummer O; Giuliani A; Gruber HJ; Pieber TR; Obermayer-Pietsch B
    Eur J Endocrinol; 2011 May; 164(5):741-9. PubMed ID: 21389086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma visfatin level in women with polycystic ovary syndrome.
    Dıkmen E; Tarkun I; Cantürk Z; Cetınarslan B
    Gynecol Endocrinol; 2011 Jul; 27(7):475-9. PubMed ID: 20586547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apelin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome.
    Altinkaya SÖ; Nergiz S; Küçük M; Yüksel H
    Eur J Obstet Gynecol Reprod Biol; 2014 May; 176():168-72. PubMed ID: 24642195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Apelin and Insulin Resistance in Patients with PCOS and Therapeutic Effect of Drospirenone-Ethinylestradiol Plus Metformin.
    Sun X; Wu X; Zhou Y; Yu X; Zhang W
    Med Sci Monit; 2015 Aug; 21():2547-52. PubMed ID: 26314870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome.
    Kowalska I; Straczkowski M; Nikolajuk A; Adamska A; Karczewska-Kupczewska M; Otziomek E; Wolczynski S; Gorska M
    Hum Reprod; 2007 Jul; 22(7):1824-9. PubMed ID: 17582143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma visfatin level in lean women with PCOS: relation to proinflammatory markers and insulin resistance.
    Gen R; Akbay E; Muslu N; Sezer K; Cayan F
    Gynecol Endocrinol; 2009 Apr; 25(4):241-5. PubMed ID: 19408173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D in polycystic ovary syndrome: Relationship to obesity and insulin resistance.
    Joham AE; Teede HJ; Cassar S; Stepto NK; Strauss BJ; Harrison CL; Boyle J; de Courten B
    Mol Nutr Food Res; 2016 Jan; 60(1):110-8. PubMed ID: 26255991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased plasma visfatin concentrations in women with polycystic ovary syndrome.
    Chan TF; Chen YL; Chen HH; Lee CH; Jong SB; Tsai EM
    Fertil Steril; 2007 Aug; 88(2):401-5. PubMed ID: 17335820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical significance and changes of serum visfatin, adiponectin and leptin levels in patients with polycystic ovarian syndrome].
    Wang Y; Yu P
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Jan; 34(1):72-5. PubMed ID: 19197132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.